Hyperprolactinemia: New assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation;Hiperprolactinemia: Novo ensaio, mais específico para as formas monoméricas, não elimina a necessidade de pesquisa de macroprolactina por precipitação com polietilenoglicol

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 9, 2010, Pages 856-857

  Vieira, José Gilberto H ^a   Tachibana, Teresinha T ^a   Ferrer, Cláudia M ^a   de Sá, José ^a   Biscolla, Rosa Paula ^a   Hoff, Ana O ^a   Kanashiro, Ina ^a  

^a Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952017750     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000900013     Document Type: Letter

References (13)

1. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab. 1974;39:928-935.
2. Glezer A, Soares CRJ, Vieira JGH, Gianella-Neto D, Ribela MTCP, Goffin V, et al. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J Clin Endocrinol Metab. 2006;91:1048-1055.
3. Hattori N, Nakayama Y, Kitagawa K, Ishihara T, Saiki Y, Inagaki C. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia. J Endocrinol. 2006;190:287-293.
4. Vilar L, Moura E, Canadas V, Gusmão A, Campos R, Leal E, et al. Prevalência da macroprolactinemia entre 115 pacientes com hiperprolactinemia. Arq Bras Endocrinol Metab. 2007;51:86-91.
5. Vieira JGH, Tachibana TT, Obara LH, Maciel RMB. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactin. Clin Chem. 1998;44:1758-1759.
6. Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassays platforms. Clin Chem. 2008;54:1673-1681.
7. Fahie-Wilson M. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem. 2000;46:2022-2023.
8. Fahie-Wilson M, Bieglmayer C, Kratzch J, Nusbaumer C, Roth HJ, Zaninotto M, et al. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Clin Lab. 2007;53:301-307.
9. Jassam NF, Paterson A, Lippiatt C, Barth JH. Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period. Ann Clin Biochem. 2009;46:501-504.
10. Byrne B, O'Shea P, Barrett P, Tormey W. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin. Clin Chem Lab Med. 2010;48:205-208.
11. Hauache OM, Rocha AJ, Maia Jr ACM, Maciel RMB, Vieira JGH. Screening for macroprolactinaemia and pituitary imaging studies Clin Endocrinol. 2002:57:327-331.
12. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab. 2005;90:3927-3932.
13. de Soárez PC, Souza MCAL, Vieira JGH, Ferraz MB. The effect of identifying macroprolactinemia on health-care utilization and costs in patients with elevated prolactin levels. Value Health. 2009;12:930-934.